A cell is fundamentally a container—a vessel that encapsulates life at the most basic level. Many biologists believe ...
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of ...
Last year Radxa introduced a mini-ITX motherboard called the Orion O6 that has a 12-core processor featuring high-performance Arm-based CPU cores and an NPU that delivers up to 30 TOPS of AI ...
The life sciences regulatory and compliance market is projected to grow at a CAGR of approximately 11% over the forecast period. This growth is driven by factors such as increased regulatory scrutiny, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Chicago's life-sciences market ...
The life sciences industry is at a turning point. The pressures are mounting—shorten development timelines, meet regulatory demands and deliver therapies that patients actually need in the real world.
VAUGHAN, Ontario — LGC Group, a global leader in life sciences, today officially opened its new Organic Chemistry Synthesis Centre of Excellence in Vaughan, Ontario, following a CAD$100 million ...
As global scientific and regulatory landscapes shift, companies across the life sciences sector are under growing pressure to adapt. For Phenomenex, a global leader in separation sciences, that means ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Frazier Life Sciences (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the closing of Frazier Life Sciences XII, L.P. (FLS ...
Nasdaq-listed 180 Life Sciences Corp plans to invest heavily in Ether and rebrand as ETHZilla Corporation, a strategic pivot away from its biotechnology origins amid mounting losses. On Tuesday, the ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. A battle between ministers and the pharmaceutical industry over drug prices has forced the UK government to ...
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development, marketing, and sale of innovative treatments and therapies, including those for rare ...